We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$9.15M
Cap. Flow
-$18.1M
Cap. Flow %
-12.5%
Top 10 Hldgs %
26.79%
Holding
704
New
1
Increased
73
Reduced
49
Closed
564

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$269K
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$197K
3
MO icon
Altria Group
MO
+$144K
4
MPT
Medical Properties Trust
MPT
+$127K
5
XOM icon
ExxonMobil
XOM
+$117K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$582K
2
MPC icon
Marathon Petroleum
MPC
+$200K
3
AER icon
AerCap
AER
+$196K
4
XPO icon
XPO
XPO
+$195K
5
CPB icon
Campbell Soup
CPB
+$186K

Sector Composition

Rank Sector Weight
1 Technology 16.31%
2 Healthcare 10.05%
3 Consumer Staples 8.95%
4 Communication Services 7.78%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
C icon
126
Citigroup
C
$226B
$233K 0.16%
2,914
+3
+0.1% +$222
AXP icon
127
American Express
AXP
$230B
$232K 0.16%
1,863
+307
+20% +$36.7K
NEA icon
128
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.42B
$232K 0.16%
16,146
-2,500
-13% -$35.5K
TSM icon
129
TSMC
TSM
$2.18T
$227K 0.16%
3,900
– –
XLY icon
130
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$220K 0.15%
3,502
+8
+0.2% +$487
VEA icon
131
Vanguard FTSE Developed Markets ETF
VEA
$236B
$204K 0.14%
+4,627
New +$197K
IVW icon
132
iShares S&P 500 Growth ETF
IVW
$77.6B
$202K 0.14%
4,180
+32
+0.8% +$1.48K
MNDT
133
DELISTED
Mandiant, Inc. Common Stock
MNDT
$178K 0.12%
10,764
-2,898
-21% -$46.5K
NMZ icon
134
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.22B
$156K 0.11%
11,000
– –
FMO
135
DELISTED
Fiduciary/Claymore Energy Infrastructure Fund
FMO
$100K 0.07%
2,527
– –
ACB
136
Aurora Cannabis
ACB
$185M
$75K 0.05%
289
-25
-8% -$9.32K
ATNM icon
137
Actinium Pharmaceuticals
ATNM
$25M
$2K ﹤0.01%
359
– –
AA icon
138
Alcoa
AA
$13.2B
– –
-44
Closed -$1K
AAL icon
139
American Airlines Group
AAL
$10.6B
– –
-2,866
Closed -$77K
AB icon
140
AllianceBernstein
AB
$3.47B
– –
-1,480
Closed -$43K
ABEO icon
141
Abeona Therapeutics
ABEO
$413M
– –
-19
Closed -$1K
ACAD icon
142
Acadia Pharmaceuticals
ACAD
$5.03B
– –
-492
Closed -$18K
ACN icon
143
Accenture
ACN
$108B
– –
-345
Closed -$66K
ACWI icon
144
iShares MSCI ACWI ETF
ACWI
$33.5B
– –
-267
Closed -$20K
ADBE icon
145
Adobe
ADBE
$105B
– –
-267
Closed -$74K
ADP icon
146
Automatic Data Processing
ADP
$108B
– –
-1,000
Closed -$161K
ADSK icon
147
Autodesk
ADSK
$52.6B
– –
-390
Closed -$58K
AEP icon
148
American Electric Power
AEP
$68.4B
– –
-303
Closed -$28K
AER icon
149
AerCap
AER
$23.8B
– –
-3,588
Closed -$196K
AFL icon
150
Aflac
AFL
$62.6B
– –
-285
Closed -$15K
4 5
6
7 8

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Truvestments Capital held 704 positions worth $144M, down 6% from $154M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital withdrew a net $18.1M in Q4 2019, closing 564 positions and reducing 49 holdings. Its most notable exit was Celgene Corp, an estimated $582K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Truvestments Capital opened a new position in Vanguard FTSE Developed Markets ETF worth $204K.

  • Truvestments Capital's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 4,627 shares worth $204K.
  • Truvestments Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $269K increase.
  • Truvestments Capital's biggest Q4 2019 reduction was Apple, cutting an estimated $151K.
  • Truvestments Capital fully exited Celgene Corp in Q4 2019, selling an estimated $582K.
  • Truvestments Capital's ten largest holdings make up 27% of its $144M portfolio in Q4 2019.
  • Truvestments Capital opened 1 new position and closed 564 in Q4 2019.
  • Truvestments Capital's portfolio value fell 6% quarter-over-quarter to $144M.

Based on Truvestments Capital's 13F filing for Q4 2019, filed 29 Jan 2020.